Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Kos and Jerini sign agreement for icatibant in U.S. and Canada

Nov. 9, 2005

New data on the effects, safety and pharmacokinetics of estetrol

Nov. 8, 2005

ISIS-301012 begins phase II statin combination study for high cholesterol

Nov. 8, 2005

Sumitomo prepares and tests sulfonamide derivatives for hyperlipidemia, arteriosclerosis, etc.

Nov. 8, 2005

Further funding for obesity drug development at Adipogen

Nov. 8, 2005

Emisphere cleared for phase II oral insulin study in India

Nov. 8, 2005

ACTOplus met available in U.S. for type 2 diabetes

Nov. 7, 2005

Estrogen receptor modulators for hot flushes prepared and tested at Merck & Co.

Nov. 4, 2005

Recent patents disclose novel agents for the treatment of diabetes

Nov. 4, 2005

Miglustat shows promise in the management of children with Niemann-Pick disease

Nov. 4, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...